A copy of the slides for my talk on how we can meaningfully improve diversity and inclusion in emergency care research, at the Royal College of Emergency Medicine Research Engagement Day in May 2024.
HealthBIO 2020_Philippe Arnez_LS CancerDiagBusiness Turku
The document describes DIAGMMR®, a quantitative functional test that can accurately detect Lynch syndrome, a hereditary cancer syndrome responsible for up to 80% of colorectal cancers. DIAGMMR® aims to address the low diagnostic rates of Lynch syndrome which is currently only diagnosed in about 5% of cases, allowing those at high risk to take preventative measures to reduce cancer risks. The company's goal is for DIAGMMR® to become the global standard test for Lynch syndrome diagnosis.
Trailblazing scientists who are the backbone of our industry. These are the people that discover the molecules and develop the medicines to tackle the toughest diseases we face in society.
The document discusses key concepts in quality management and patient safety. It defines patient safety as freedom from accidental injury during care according to the Institute of Medicine. Medical errors in the US healthcare system lead to tens of thousands of deaths annually and billions in costs. Most medical errors are systems-driven rather than due to individual incompetence. The Swiss cheese model of accident analysis and focus on human factors engineering can help identify root causes of errors and design safer systems through checklists, computerized order entry, and other interventions. Reactive risk analysis includes root cause analysis while proactive analysis uses failure mode and effects analysis. The document outlines definitions of adverse events, sentinel events, and near misses, as well as seven steps hospitals can take to
The document discusses key concepts in quality management and patient safety, including definitions of safety in healthcare. It notes that medical errors lead to tens of thousands of deaths annually in the US healthcare system according to the 1999 IOM report. Both active errors at the sharp end and latent errors in system design can cause harm. While individuals may slip or make mistakes, most medical errors are systems-driven according to IHI research. A safety culture and focus on systems improvements rather than blame can help reduce errors. The Swiss cheese model of accident analysis and human factors engineering are approaches to analyzing root causes and designing safer systems.
Top 4 global trends in life science and healthcare and why is this important ...STELIOS PIGADIOTIS
Top Global Trend Areas of Scientific advancements in Life Science and Healthcare
How Middle Eastern Healthcare Ecosystem can Benefit for these Advancement
3 reasons for a drug and alcohol program in the construction industryresile
The document outlines 3 reasons for implementing a drug and alcohol program in the construction industry:
1. Drug use is high in the construction industry compared to other industries, with workers self-reporting higher rates of alcohol and drug use.
2. A well-designed alcohol and drug program can make the workplace safer since construction workers perform safety-critical tasks, and those under the influence of drugs are 3-4 times more likely to be involved in an incident.
3. It is also legally required under workplace health and safety acts and common law, as employers have an obligation to ensure workers can perform duties safely without harming themselves or others.
HealthBIO 2020_Philippe Arnez_LS CancerDiagBusiness Turku
The document describes DIAGMMR®, a quantitative functional test that can accurately detect Lynch syndrome, a hereditary cancer syndrome responsible for up to 80% of colorectal cancers. DIAGMMR® aims to address the low diagnostic rates of Lynch syndrome which is currently only diagnosed in about 5% of cases, allowing those at high risk to take preventative measures to reduce cancer risks. The company's goal is for DIAGMMR® to become the global standard test for Lynch syndrome diagnosis.
Trailblazing scientists who are the backbone of our industry. These are the people that discover the molecules and develop the medicines to tackle the toughest diseases we face in society.
The document discusses key concepts in quality management and patient safety. It defines patient safety as freedom from accidental injury during care according to the Institute of Medicine. Medical errors in the US healthcare system lead to tens of thousands of deaths annually and billions in costs. Most medical errors are systems-driven rather than due to individual incompetence. The Swiss cheese model of accident analysis and focus on human factors engineering can help identify root causes of errors and design safer systems through checklists, computerized order entry, and other interventions. Reactive risk analysis includes root cause analysis while proactive analysis uses failure mode and effects analysis. The document outlines definitions of adverse events, sentinel events, and near misses, as well as seven steps hospitals can take to
The document discusses key concepts in quality management and patient safety, including definitions of safety in healthcare. It notes that medical errors lead to tens of thousands of deaths annually in the US healthcare system according to the 1999 IOM report. Both active errors at the sharp end and latent errors in system design can cause harm. While individuals may slip or make mistakes, most medical errors are systems-driven according to IHI research. A safety culture and focus on systems improvements rather than blame can help reduce errors. The Swiss cheese model of accident analysis and human factors engineering are approaches to analyzing root causes and designing safer systems.
Top 4 global trends in life science and healthcare and why is this important ...STELIOS PIGADIOTIS
Top Global Trend Areas of Scientific advancements in Life Science and Healthcare
How Middle Eastern Healthcare Ecosystem can Benefit for these Advancement
3 reasons for a drug and alcohol program in the construction industryresile
The document outlines 3 reasons for implementing a drug and alcohol program in the construction industry:
1. Drug use is high in the construction industry compared to other industries, with workers self-reporting higher rates of alcohol and drug use.
2. A well-designed alcohol and drug program can make the workplace safer since construction workers perform safety-critical tasks, and those under the influence of drugs are 3-4 times more likely to be involved in an incident.
3. It is also legally required under workplace health and safety acts and common law, as employers have an obligation to ensure workers can perform duties safely without harming themselves or others.
Every day, we rely on the health care system to provide us with the necessary means to live a healthy life and every day, new health care technologies come to life. The thing is that this sort of innovation rarely respects the traditional boundaries between the different health care professions. Check out this based on my master's thesis on a new screening technology for diabetic eye disease.
[DSC Europe 23][DigiHealth] Dimitrios Kalogeropoulos A Sustainable Future for...DataScienceConferenc1
Dr Dimitrios Kalogeropoulos discusses risks and challenges with open learning AI in healthcare from 2003 to 2023. Key points include:
1) AI may restrict, discriminate, or exclude patients from treatment.
2) Issues around privacy/security attacks, deep fakes, and data poisoning.
3) Threats to digital sovereignty and economies from misuse of AI.
4) Lack of high-quality clinical trials and real-world data hinders adoption of AI in healthcare.
This document provides quantitative data and comparisons on aging populations and healthcare systems across several European countries and the United States. Some key findings presented include: the percentage of populations over 65 and over 80 is increasing dramatically in coming decades, especially in Italy, Spain and France; potential support ratios are declining as populations age in all countries studied; and satisfaction with healthcare systems is generally low across Europe despite high levels of public and private spending on health as a percentage of GDP.
Kim Solez Yukako Yagi Digital transplant pathology white paperKim Solez ,
This document discusses digital transplant pathology and proposes initial projects for a working group. It begins with background on digital pathology and its potential to address declining interest in pathology. Only 30 of over 1000 pathology departments worldwide were fully digitized in 2019. The document then discusses exponentially advancing technologies and influential figures in the field. It proposes that the working group focus on practical digital pathology examples and first projects related to transplant pathology. One such example discussed is automated fluorescence in situ hybridization (FISH) quantification from whole slide images using deep learning.
This document summarizes a report by IQ4I Research & Consultancy Pvt. Ltd. on the global diagnostic imaging market from 2014 to 2020. Key findings include:
- The global market was worth $XX billion in 2013 and is expected to grow at a CAGR of over 5.1% to reach $XX billion by 2020.
- North America accounted for the largest market share in 2013. However, Asia-Pacific is expected to see the fastest growth at a CAGR of 6.5% during the forecast period.
- Common diagnostic imaging modalities analyzed included CT, MRI, ultrasound, X-ray, and nuclear imaging. CT commanded the largest market share in 2013.
Organs-On-Chips Market and Technology Landscape 2019 report by Yole Développe...Yole Developpement
This report provides an analysis of the organ-on-chip market and technology from 2019-2024. It includes market forecasts for organ-on-chip device sales and services through 2024. It also examines the organ-on-chip ecosystem and supply chain, as well as technology trends like the types of organ models, devices, materials, and cell sources used. The report aims to help pharmaceutical, biotech, and other companies understand organ-on-chip technologies and how they can be used for drug development, disease modeling, and toxicity testing applications.
Traditional Investment Appraisal Techniques Can Not Cope...Tammy Lacy
The document discusses traditional investment appraisal techniques and their inability to cope with fast changing manufacturing environments. It defines investment and discusses several traditional techniques, including payback period, accounting rate of return, net present value, internal rate of return, and profitability index. It examines how technological evolution challenges the suitability of these traditional methods and their adaptability to today's fast-paced industry demands.
01 merlin wilcox_research as a route in to global health_personal reflectionsjintc
Presentation given by Dr Merlin Wilcon on Friday 13th April 2012 to the 4th RCGP Junior International Committee Annual General Meeting in Croydon, London
Cemal H. Guvercin MedicReS 5th World Congress MedicReS
Ethical Issues in Artifical Intelligence Applied to Medicine Presentation to MedicReS 5th World Congress on October 19,25,2015 in New York by Cemal H. Guvercin, MD, PhD
This document provides information on causes, types, and prevention of accidents. It discusses road traffic accidents as the leading cause of death worldwide, with key risk factors including speed, alcohol, and lack of safety measures. Domestic accidents like drowning, burns, falls, and poisoning are also detailed. Prevention strategies addressed for different accident types include education, elimination of hazards, enforcement of laws, and emergency management. Industrial, railway, and violence-related accidents are also briefly outlined.
Christopher Anderson SPHR CBS VP HR Why is hrJerome Matthews
Why is HR in the Biotech Industry different ?
Biotechnology is one of the most research intensive industries in the world. The first biotechnology product earning FDA approval was for synthetic “human” insulin in 1982 and was developed by Genentech and Eli Lilly.
National Programme for Control of BlindnessKEM Hospital
This document discusses community ophthalmology and the burden of blindness in India. It provides an overview of community ophthalmology, which aims to provide accessible eye care services. The main causes of blindness in India are cataract (62.6%), refractive error (19.7%), and corneal blindness (0.9%). National programs like the National Programme for Control of Blindness and Vision 2020 aim to reduce blindness. The NPCB focuses on increasing cataract surgeries and screening/treating refractive errors in schoolchildren.
This document discusses efforts to reduce cervical cancer in Peru through analyzing the global value chain of a point-of-care colposcope called POCkeT. Field interviews were conducted with public and private sector organizations in Lima, Peru to understand how POCkeT could fit within existing healthcare infrastructure and clinical workflows. The interviews revealed opportunities to leverage telemedicine, train midwives on POCkeT usage, clarify midwife and patient roles, and improve coordination between organizations. Mapping the POCkeT value chain showed its traditional focus on manufacturing and sales. However, the ultimate goal is solving the problem of cervical cancer, requiring a holistic GVC analysis of all actors and factors involved in prevention, screening and treatment.
Example of an EIT Health project: Learnings & outcomesEITHEALTH
The document discusses the Rare Cancer Knowledge Innovation Community (KIC), which aims to address inequalities in rare cancer care across Europe. The KIC will create platforms and services utilizing technology and medical expertise to help rare cancer patients. It sees opportunities to improve patient care, reduce costs, and support innovation through education. The KIC brings together leaders from Oxford University, GE Healthcare, and EORTC to leverage their networks and technical tools like GE Case Exchange and the EORTC SPECTA data portal. It seeks new clinical, academic, corporate, SME, regulatory, and patient partners to expand globally and establish reference centers for rare cancers. The goal is to improve diagnostics, research, clinical trials, and personalized medicine
09 CeoMeeting- Session 4- Medicines for MalariaMLSCF
The document discusses product development partnerships (PDPs) that work to develop medicines and treatments for diseases that disproportionately impact developing countries and have limited commercial incentives. It provides Medicine for Malaria Venture (MMV) as a key example of a PDP focused on developing antimalarial drugs. MMV has developed over a dozen antimalarial candidates and products over its existence, including a pediatric-friendly version of Coartem through partnerships with Novartis. PDPs have grown substantially over the past decade and play a central role in driving neglected disease product pipelines.
Winston Tilghman, MD
Medical Director, STD Controller
HIV, STD & Hepatitis Branch of Public Health Services
County of San Diego Health & Human Services Agency
This is my talk for EUSEM 2020, in the Acute Coronary Syndromes session. We have seen some terrific advances in diagnostic technology in recent years. Decision aids and high-sensitivity cardiac troponin assays allow us to rapidly 'rule out' and 'rule in' the diagnosis of acute coronary syndrome (ACS) for many patients. But what about those who remain in the 'observation zone' or 'grey zone'? How do we ultimately decide whether they have an acute coronary syndrome, and how best to manage their care? In this talk I cover some key evidence to addres those questions, I illustrate this with three cases and I conclude that there are two key questions that we must answer for each patient we see in order to make these decisions.
More Related Content
Similar to What can we really do to give meaning and momentum to equality, diversity and inclusion in EM research?
Every day, we rely on the health care system to provide us with the necessary means to live a healthy life and every day, new health care technologies come to life. The thing is that this sort of innovation rarely respects the traditional boundaries between the different health care professions. Check out this based on my master's thesis on a new screening technology for diabetic eye disease.
[DSC Europe 23][DigiHealth] Dimitrios Kalogeropoulos A Sustainable Future for...DataScienceConferenc1
Dr Dimitrios Kalogeropoulos discusses risks and challenges with open learning AI in healthcare from 2003 to 2023. Key points include:
1) AI may restrict, discriminate, or exclude patients from treatment.
2) Issues around privacy/security attacks, deep fakes, and data poisoning.
3) Threats to digital sovereignty and economies from misuse of AI.
4) Lack of high-quality clinical trials and real-world data hinders adoption of AI in healthcare.
This document provides quantitative data and comparisons on aging populations and healthcare systems across several European countries and the United States. Some key findings presented include: the percentage of populations over 65 and over 80 is increasing dramatically in coming decades, especially in Italy, Spain and France; potential support ratios are declining as populations age in all countries studied; and satisfaction with healthcare systems is generally low across Europe despite high levels of public and private spending on health as a percentage of GDP.
Kim Solez Yukako Yagi Digital transplant pathology white paperKim Solez ,
This document discusses digital transplant pathology and proposes initial projects for a working group. It begins with background on digital pathology and its potential to address declining interest in pathology. Only 30 of over 1000 pathology departments worldwide were fully digitized in 2019. The document then discusses exponentially advancing technologies and influential figures in the field. It proposes that the working group focus on practical digital pathology examples and first projects related to transplant pathology. One such example discussed is automated fluorescence in situ hybridization (FISH) quantification from whole slide images using deep learning.
This document summarizes a report by IQ4I Research & Consultancy Pvt. Ltd. on the global diagnostic imaging market from 2014 to 2020. Key findings include:
- The global market was worth $XX billion in 2013 and is expected to grow at a CAGR of over 5.1% to reach $XX billion by 2020.
- North America accounted for the largest market share in 2013. However, Asia-Pacific is expected to see the fastest growth at a CAGR of 6.5% during the forecast period.
- Common diagnostic imaging modalities analyzed included CT, MRI, ultrasound, X-ray, and nuclear imaging. CT commanded the largest market share in 2013.
Organs-On-Chips Market and Technology Landscape 2019 report by Yole Développe...Yole Developpement
This report provides an analysis of the organ-on-chip market and technology from 2019-2024. It includes market forecasts for organ-on-chip device sales and services through 2024. It also examines the organ-on-chip ecosystem and supply chain, as well as technology trends like the types of organ models, devices, materials, and cell sources used. The report aims to help pharmaceutical, biotech, and other companies understand organ-on-chip technologies and how they can be used for drug development, disease modeling, and toxicity testing applications.
Traditional Investment Appraisal Techniques Can Not Cope...Tammy Lacy
The document discusses traditional investment appraisal techniques and their inability to cope with fast changing manufacturing environments. It defines investment and discusses several traditional techniques, including payback period, accounting rate of return, net present value, internal rate of return, and profitability index. It examines how technological evolution challenges the suitability of these traditional methods and their adaptability to today's fast-paced industry demands.
01 merlin wilcox_research as a route in to global health_personal reflectionsjintc
Presentation given by Dr Merlin Wilcon on Friday 13th April 2012 to the 4th RCGP Junior International Committee Annual General Meeting in Croydon, London
Cemal H. Guvercin MedicReS 5th World Congress MedicReS
Ethical Issues in Artifical Intelligence Applied to Medicine Presentation to MedicReS 5th World Congress on October 19,25,2015 in New York by Cemal H. Guvercin, MD, PhD
This document provides information on causes, types, and prevention of accidents. It discusses road traffic accidents as the leading cause of death worldwide, with key risk factors including speed, alcohol, and lack of safety measures. Domestic accidents like drowning, burns, falls, and poisoning are also detailed. Prevention strategies addressed for different accident types include education, elimination of hazards, enforcement of laws, and emergency management. Industrial, railway, and violence-related accidents are also briefly outlined.
Christopher Anderson SPHR CBS VP HR Why is hrJerome Matthews
Why is HR in the Biotech Industry different ?
Biotechnology is one of the most research intensive industries in the world. The first biotechnology product earning FDA approval was for synthetic “human” insulin in 1982 and was developed by Genentech and Eli Lilly.
National Programme for Control of BlindnessKEM Hospital
This document discusses community ophthalmology and the burden of blindness in India. It provides an overview of community ophthalmology, which aims to provide accessible eye care services. The main causes of blindness in India are cataract (62.6%), refractive error (19.7%), and corneal blindness (0.9%). National programs like the National Programme for Control of Blindness and Vision 2020 aim to reduce blindness. The NPCB focuses on increasing cataract surgeries and screening/treating refractive errors in schoolchildren.
This document discusses efforts to reduce cervical cancer in Peru through analyzing the global value chain of a point-of-care colposcope called POCkeT. Field interviews were conducted with public and private sector organizations in Lima, Peru to understand how POCkeT could fit within existing healthcare infrastructure and clinical workflows. The interviews revealed opportunities to leverage telemedicine, train midwives on POCkeT usage, clarify midwife and patient roles, and improve coordination between organizations. Mapping the POCkeT value chain showed its traditional focus on manufacturing and sales. However, the ultimate goal is solving the problem of cervical cancer, requiring a holistic GVC analysis of all actors and factors involved in prevention, screening and treatment.
Example of an EIT Health project: Learnings & outcomesEITHEALTH
The document discusses the Rare Cancer Knowledge Innovation Community (KIC), which aims to address inequalities in rare cancer care across Europe. The KIC will create platforms and services utilizing technology and medical expertise to help rare cancer patients. It sees opportunities to improve patient care, reduce costs, and support innovation through education. The KIC brings together leaders from Oxford University, GE Healthcare, and EORTC to leverage their networks and technical tools like GE Case Exchange and the EORTC SPECTA data portal. It seeks new clinical, academic, corporate, SME, regulatory, and patient partners to expand globally and establish reference centers for rare cancers. The goal is to improve diagnostics, research, clinical trials, and personalized medicine
09 CeoMeeting- Session 4- Medicines for MalariaMLSCF
The document discusses product development partnerships (PDPs) that work to develop medicines and treatments for diseases that disproportionately impact developing countries and have limited commercial incentives. It provides Medicine for Malaria Venture (MMV) as a key example of a PDP focused on developing antimalarial drugs. MMV has developed over a dozen antimalarial candidates and products over its existence, including a pediatric-friendly version of Coartem through partnerships with Novartis. PDPs have grown substantially over the past decade and play a central role in driving neglected disease product pipelines.
Winston Tilghman, MD
Medical Director, STD Controller
HIV, STD & Hepatitis Branch of Public Health Services
County of San Diego Health & Human Services Agency
Similar to What can we really do to give meaning and momentum to equality, diversity and inclusion in EM research? (20)
This is my talk for EUSEM 2020, in the Acute Coronary Syndromes session. We have seen some terrific advances in diagnostic technology in recent years. Decision aids and high-sensitivity cardiac troponin assays allow us to rapidly 'rule out' and 'rule in' the diagnosis of acute coronary syndrome (ACS) for many patients. But what about those who remain in the 'observation zone' or 'grey zone'? How do we ultimately decide whether they have an acute coronary syndrome, and how best to manage their care? In this talk I cover some key evidence to addres those questions, I illustrate this with three cases and I conclude that there are two key questions that we must answer for each patient we see in order to make these decisions.
Managing compassion fatigue in Emergency MedicineRick Body
My talk at the Royal College of Emergency Medicine day on wellbeing, 2018. Managing compassion fatigue. What causes compassion fatigue and burnout and how can we combat them?
Biomarkers: The Good, The Bad and the UglyRick Body
My talk at the Royal College of Physicians Acute Medicine Day, 2018. What are the key points about how we should be using biomarkers in practice? My talk addresses the importance of clinical context, using biomarker concentrations as continuous variables and remembering that biomarkers are not disease-specific. They have to be interpreted carefully by a clinician, and should not be used alone to make diagnoses.
https://www.rcplondon.ac.uk/events/acute-medicine-3
Research in emergency medicine Registrars Day 2018Rick Body
Question: Who's job is it to do clinical research in Emergency Medicine?
Answer: It's everyone's! All of us have a responsibility to offer patients an opportunity to take part in clinical research - but there are different levels of (and opportunities for) involvement for us, as clinicians.
Timely, Convenient and Sensitive: Is Point of Care Troponin Testing the Future?Rick Body
Point of care troponin testing is an extremely topical concept in Emergency Medicine. In this talk I'll explore the evidence for this technology, looking at the various assays available and how they can help us. I'll also ask what the future might look like, thanks to new technology like the Manchester Acute Coronary Syndromes (MACS) decision aid. Presented at Acute & General Medicine, London Excel, 2016
The things nobody told you about troponinRick Body
My talk at #RCEM15 in Manchester. What is a high sensitivity troponin assay? How can they help us? Can we use point of care troponins in our practice? Pointers for practice for those working in Emergency Medicine.
Power to the people: Overcoming the tsunami of demand in Emergency MedicineRick Body
My talk on 18th October 2016 at 'The Accident and Emergency Summit' in Salford.
The key to sustainable healthcare may be to empower people to share key decisions with clinicians.
Are clinicians the wrong people to make decisions about individual patients’ healthcare?
How can technology help us to better calculate and communicate risk and uncertainty with patients?
Could empowering patients ensure a more sustainable future for Emergency Medicine?
Acute Coronary Syndromes Diagnosis, Version 2.0Rick Body
Serial troponin testing and 'binary diagnostics' are part of a now outdated paradigm. They have important limitations. In this talk I discuss how we can move to a new paradigm, a new world. This is a world that embraces probability and uncertainty. It's a world where uncertainty can be shared with patients to facilitate individualized shared decision making. It's a world where the patient's individual characteristics can guide the treatment we prescribe. It's a world where care is provided wherever the patient is, not wherever the hospital happens to be. It's a world where the diagnostic tests can improve themselves over time using machine learning.
That world is here. The Troponin-only Manchester Acute Coronary Syndromes (T-MACS) rule opens up a whole new world of possibilities for ACS diagnosis. In this talk I illustrate exactly how exciting that future looks.
War on Troponinitis: How to Beat the Plague, at #RCEM16beachRick Body
They say that modern medicine is facing a plague of troponinitis thanks to high sensitivity troponin. Is it true? How do we beat it? In this presentation I covered everything from troponin reference ranges to sex-specific cut-offs to absolute delta changes. My talk from #RCEM16beach, the Annual Scientific Conference of the Royal College of Emergency Medicine
The drone will see you now: revolutionising heart attack diagnosisRick Body
My talk at the Manchester Metropolitan University (MMU) Science & Engineering Symposium 2016 (www.sciengsymp.co.uk), with a bit shout out to TUDelft and Alex Momont for their terrific take on using drones in cardiac arrest. Would this work for acute coronary syndromes too?
For more on the drones, see: http://www.alecmomont.com/projects/dronesforgood/
One shot to rule out acute coronary syndromes: mission possible?Rick Body
My talk from the ProCardio symposium in Rome, 2016. Can we rule out acute coronary syndromes with a single blood test? The limit of detection rule out strategy (LoD strategy); Manchester Acute Coronary Syndromes (MACS) decision rule and troponin-only MACS (T-MACS) rules are all discussed.
Practising evidence-based medicine requires skill. In this talk from the SMACC Dublin 2016 EBM workshop, I examine the ingredients of a good critical appraisal for a diagnostic study. This is the tool we need to use to determine what evidence really means for our practice.
War on troponinitis: Rick Body at 9th Dutch Sea Emergency Medicine Conference...Rick Body
My talk at the 9th Dutch North Sea Emergency Medicine Conference, 2016. How to battle troponinitis: top tips for overcoming the problems we have with false positive high sensitivity troponin concentrations.
The challenge and value of research in emergency medicine and critical careRick Body
What has clinical research in Emergency Medicine and Critical Care got to do with Oskar Schindler? Not so much, you might think. But in this talk from the UK Critical Care Technologists Forum 2016 I explore the similarities. There are more than you might think. And there are more reasons to get involved in clinical research than you might think, too...
Evidence-based medicine and evidence-based practice are core principles for the doctor who wants to achieve excellence. In this talk from #SWEETS16 I use an online dating analogy to explain the core principles of analysing diagnostic accuracy.
My talk from #SWEETS16, in which I ask whether patients with isolated distal deep vein thrombosis may benefit from anticoagulation. With a huge shout out to Dan Horner and Kerstin De Wit, my friends and colleagues who are leading international experts in this field.
Simple Steps to Make Her Choose You Every DayLucas Smith
Simple Steps to Make Her Choose You Every Day" and unlock the secrets to building a strong, lasting relationship. This comprehensive guide takes you on a journey to self-improvement, enhancing your communication and emotional skills, ensuring that your partner chooses you without hesitation. Forget about complications and start applying easy, straightforward steps that make her see you as the ideal person she can't live without. Gain the key to her heart and enjoy a relationship filled with love and mutual respect. This isn't just a book; it's an investment in your happiness and the happiness of your partner
Bashundhara Toiletries Logo Guideline 2024khabri85
It outlines the basic identity elements such as symbol, logotype, colors, and typefaces. It provides examples of applying the identity to materials like letterhead, business cards, reports, folders, and websites.
About CentiUP - Introduction and Products.pdfCentiUP
A heightened child formula, with the trio of Nano Calcium, HMO, and DHA mixed in the golden ratio, combined with NANO technology to help nourish the body deeply and comprehensively, helps children increase height, boost brain power, and improve the immune system and overall well-being.
8. CONTRAINDICATIONS: MOVEMENT IN YOGA
8. Introduction to Contraindications
Students come to yoga classes with a variety of physical, mental, and emotional conditions that should be given special attention and support by teachers.
While making clear the distinction between yoga teacher and licensed medical or mental health professional, as teachers we are responsible for creating a safe and supportive environment for all students, including those with injuries, depression, age-related needs, and conditions such as pregnancy and menopause.
Here we will look at practical approaches to working with students whose bodies, hearts, and minds (which are not really separate) indicate the need for special accommodation in classes or in one-on-one sessions. Bringing a specifically yogic perspective to this aspect of teaching starts with looking at and appreciating every student as the whole person he or she is, offering tools and techniques for using various challenging conditions to heal, feel better, and move into a deeper quality of integration.
Cyclothymia Test: Diagnosing, Symptoms, Treatment, and Impact | The Lifescien...The Lifesciences Magazine
The cyclothymia test is a pivotal tool in the diagnostic process. It helps clinicians assess the presence and severity of symptoms associated with cyclothymia.
2024 Media Preferences of Older Adults: Consumer Survey and Marketing Implica...Media Logic
When it comes to creating marketing strategies that target older adults, it is crucial to have insight into their media habits and preferences. Understanding how older adults consume and use media is key to creating acquisition and retention strategies. We recently conducted our seventh annual survey to gain insight into the media preferences of older adults in 2024. Here are the survey responses and marketing implications that stood out to us.
4. We should undertake a multi-professional audit of
devices used in our field, examining potential
racial biases. We can record rashes at Skin Deep:
Optical devices
We must consider equity in all research proposals
Social, economic and health equity impacts must
be considered.
AI algorithms
Royal Colleges should produce guidance on equity and ethical
challenges of applying polygenic risk scores in our
populations.
Polygenic Risk Scores
15. How can we
do better?
Recognise specific challenges: e.g., carer
responsibilities disproportionately affect women.
01
Regulatory issues: systematic exclusion of women
of childbearing age
02
Recognise the role of under-diagnosis.
03
16. ANSWER: ZERO
In a systematic review of 148 clinical trials in
the NIHR journals library, how many recorded
the number of transgender participants?
17. The normal range for common
blood tests (e.g., haemoglobin,
troponin, NT-proBNP) is higher
for men than women.
Q: Which normal range
should be used for
transgender people?
18. The normal range for common
blood tests (e.g., haemoglobin,
troponin, NT-proBNP) is higher
for men than women.
Q: Which normal range
should be used for
transgender people?
A: For trans men, use the
cisgender male range
For trans women, use the
cisgender female range